TPL hold rights to both portfolios and such it relief from both that is being sought by the Plaintiffs. In the event that damages are granted to the Defendants, the Court, NOT TPL, will apportion them. Each patent will be assessed individually, not as a job lot. The respective owners of the patents found to be infringed will then receive a pro rata disbursement, 50/50 on any within the MMP and 100/0 with the MCM.

There will be a strict demarcation applied to the costs applicable to the separate portfolios with TPL bearing 50% of those for the MMP and all of those for the MCM.

There are just too many people involved for any unethical conduct to go unreported, in my very humble opinion.

Hopefully this will all be moot if/when the USPTO validates the MMP

I would respectfully remind you that the patents are valid until such time as the USPTO determines otherwise, and the current Plaintiffs are litigating on that understanding. Revalidation does not guarantee a settlement. Further, it does not follow that the MCM potfolio will settle with revalidation of the MMP portfolio.

This I know.

Be well